Gabelli Funds LLC Acquires 104,330 Shares of Perrigo Company plc $PRGO

Gabelli Funds LLC boosted its holdings in Perrigo Company plc (NYSE:PRGO) by 17.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 688,048 shares of the company’s stock after acquiring an additional 104,330 shares during the quarter. Gabelli Funds LLC’s holdings in Perrigo were worth $9,578,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Geneos Wealth Management Inc. increased its stake in Perrigo by 439.1% in the first quarter. Geneos Wealth Management Inc. now owns 965 shares of the company’s stock valued at $27,000 after acquiring an additional 786 shares during the period. CWM LLC increased its stake in Perrigo by 230.0% in the fourth quarter. CWM LLC now owns 2,191 shares of the company’s stock valued at $31,000 after acquiring an additional 1,527 shares during the period. Key Capital Management INC bought a new stake in Perrigo in the fourth quarter valued at about $36,000. Jones Financial Companies Lllp increased its stake in Perrigo by 89.1% in the third quarter. Jones Financial Companies Lllp now owns 1,778 shares of the company’s stock valued at $38,000 after acquiring an additional 838 shares during the period. Finally, Kestra Investment Management LLC increased its stake in Perrigo by 57.1% in the second quarter. Kestra Investment Management LLC now owns 1,766 shares of the company’s stock valued at $47,000 after acquiring an additional 642 shares during the period. Institutional investors own 95.91% of the company’s stock.

Analysts Set New Price Targets

A number of analysts recently weighed in on PRGO shares. Canaccord Genuity Group lowered their target price on shares of Perrigo from $20.00 to $17.00 and set a “buy” rating on the stock in a research note on Friday, February 27th. Weiss Ratings raised shares of Perrigo from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, May 13th. Zacks Research raised shares of Perrigo from a “strong sell” rating to a “hold” rating in a research note on Monday, April 27th. Finally, Jefferies Financial Group reaffirmed a “hold” rating on shares of Perrigo in a research note on Thursday, February 26th. One investment analyst has rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $19.33.

Perrigo Price Performance

Shares of PRGO stock opened at $10.62 on Wednesday. Perrigo Company plc has a 1 year low of $9.23 and a 1 year high of $28.43. The firm’s 50 day moving average is $10.76 and its 200-day moving average is $12.98. The firm has a market capitalization of $1.47 billion, a price-to-earnings ratio of -0.81, a PEG ratio of 1.25 and a beta of 0.52. The company has a current ratio of 2.72, a quick ratio of 1.59 and a debt-to-equity ratio of 1.45.

Perrigo (NYSE:PRGO) last announced its earnings results on Wednesday, May 6th. The company reported $0.43 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.39 by $0.04. Perrigo had a negative net margin of 43.50% and a positive return on equity of 9.96%. The company had revenue of $841.80 million for the quarter, compared to analyst estimates of $1.04 billion. During the same period in the prior year, the business earned $0.60 earnings per share. Perrigo’s quarterly revenue was down 7.2% on a year-over-year basis. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. Sell-side analysts forecast that Perrigo Company plc will post 2.14 EPS for the current fiscal year.

Perrigo Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 16th. Stockholders of record on Friday, May 29th will be given a dividend of $0.29 per share. This represents a $1.16 dividend on an annualized basis and a dividend yield of 10.9%. The ex-dividend date is Friday, May 29th. Perrigo’s dividend payout ratio is presently -8.85%.

Perrigo Profile

Perrigo Company plc is a global healthcare supplier specializing in over-the-counter (OTC) and self-care products, as well as generic prescription pharmaceuticals and active pharmaceutical ingredients. The company develops, manufactures and distributes a broad array of consumer health products, including analgesics, vitamins and supplements, digestive health remedies, topical treatments, and infant formulas. Perrigo’s focus on private-label solutions has made it a leading partner for retailers and pharmacy chains seeking high-quality, value-oriented alternatives to branded medications and health supplements.

Organized across three principal business segments—Consumer Healthcare, Prescription Pharmaceuticals and Active Pharmaceutical Ingredients—Perrigo’s operations span research and development, manufacturing, quality assurance and global distribution.